Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Menopause. 2013 Jun;20(6):631–639. doi: 10.1097/GME.0b013e31827c5c45

Table 3.

Results reported from the final models of separate logistic regression analyses examining indicators of depressive symptomatology and psychiatric treatment history in relation to experiencing any change compared to no change in menstrual cycle length.a

Any change in menstrual cycle length (n = 154) vs. No change (n = 650)
OR 95% CI p
CESD score ≥16, (1=yes, 0=no) 2.052 1.280 – 3.290 .003
Lifetime depression dx, (1=yes, 0=no) 2.986 1.569 – 5.682 .001
Lifetime antidepressant use, (1=yes, 0=no) 3.061 1.576 – 5.946 .001
Lifetime depression composite, (1=yes, 0=no)b 2.615 1.469 – 4.657 .001
a

Analyses included covariate-adjustment for age, race/ethnicity, SES, smoking, physical activity level, parity, past use of a hormonal method of birth control, and menstrual cycle length

b

The lifetime history of depression composite score is coded having received a depression diagnosis or having used anti-depressant medications (yes/no).